Celerion, a CRO to the biopharmaceutical industry, has completed additions to its research capacity and services, including a new Screening and Return Center, upgraded pharmacy compounding suites, expanded Absorption, Distribution, Metabolism and Excretion (ADME) lab capacity and fifty additional beds.   The new 40,000 sq.-ft. facility adjacent to the Phoenix, AZ clinic is designed to increase screening capacity and cater to the participant experience. It allows Celerion to better segregat...